Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins

Abstract

We have engineered two Chinese hamster ovary cell lines secreting different recombinant glycoproteins to express high levels of human β1,4-galactosyltransferase (GT, E.C. 2.4.1.38) and/or α2,3-sialyltransferase (ST, E.C. 2.4.99.6). N-linked oligosaccharide structures synthesized by cells overexpressing the glycosyltransferases showed greater homogeneity compared with control cell lines. When GT was overexpressed, oligosaccharides terminating with GlcNAc were significantly reduced compared with controls, whereas overexpression of ST resulted in sialylation of ≥90% of available branches. As expected, GT overexpression resulted in reduction of oligosaccharides terminating with GlcNAc, whereas overexpression of ST resulted in sialylation of ≥90% of available branches. The more highly sialylated glycoproteins had a significantly longer mean residence time in a rabbit model of pharmacokinetics. These experiments demonstrate the feasibility of genetically engineering cell lines to produce therapeutics with desired glycosylation patterns.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Northern blot analysis of GT and ST overexpression in cell lines secreting (A) TNFR-IgG and (B).
Figure 2: MALDI-TOF MS in (A and B) negative-ion mode and (C and D) positive-ion mode of oligosaccharides on TNK-tPA produced by (A and C) control cells and (B and D) cells reengineered to overexpress ST alone.
Figure 3: MALDI-TOF MS in negative-ion mode of oligosaccharides on TNFR-IgG produced by (A) control cells and cells reengineered to overexpress (B) GT alone (C) ST alone, and (D) both enzymes together (GT/ST).
Figure 4: MALDI-TOF MS in positive-ion mode of oligosaccharides on TNFR-IgG produced by (A) control cells and cells reengineered to overexpress (B) GT alone (C) ST alone, and (D) both enzymes together (GT/ST).
Figure 5

Similar content being viewed by others

References

  1. Goochee, C.F., Gramer M.J., Andersen, D.C., Bahr, J.C. & Rasmussen, J.R. in Frontiers in bioprocessing II (eds Todd, P., Sikdar, S.K. & Bier, M.) 198–240 (American Chemical Society, Washington DC; 1992).

    Google Scholar 

  2. Ashwell, G. & Hartford, J. Carbohydrate specific receptors of the liver. Annu. Rev. Biochem. 51, 531–554 (1982).

    Article  CAS  Google Scholar 

  3. Jenkins, N. & Curling, E.M.A. Glycosylation of recombinant proteins: problems and prospects. Enzyme Microb. Technol. 16, 354–364 (1994).

    Article  CAS  Google Scholar 

  4. Andersen, D. & Goochee, C.F. The effect of cell culture conditions on the oligosaccharide structures of recombinant glycoproteins. Curr. Opin. Biotechnol. 5, 546–549 (1994).

    Article  CAS  Google Scholar 

  5. Ashkenazi, A. et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88, 10535–10539 (1991).

    Article  CAS  Google Scholar 

  6. Keyt, B.A. et al. A faster and more potent form of tissue plasminogen activator. Proc. Natl. Acad. Sci. USA 91, 3670–3674 (1994).

    Article  CAS  Google Scholar 

  7. Varki, A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97–130 (1993).

    Article  CAS  Google Scholar 

  8. Fukuda, M.N., Sasaki, H., Lopez, L. & Fukada, M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 73, 84–89 (1989).

    CAS  PubMed  Google Scholar 

  9. Wasley, L.C. et al. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood 77, 2624–2632 (1991).

    CAS  PubMed  Google Scholar 

  10. Lee, Y.C. et al. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin: dependence on fine structural features. J. Biol. Chem. 258, 199–202 (1983).

    CAS  PubMed  Google Scholar 

  11. Jeffries, R. & Lund, J. Antibody engineering (Chemical Immunology), Vol. 65 (ed. Capra, J.D.) 111–128 (Karger Press, Basel, Switzerland; 1996).

    Google Scholar 

  12. Liu, D.T.-Y. Glycoprotein pharmaceuticals: scientific and regulatory considerations, and the US Orphan Drug Act. Trends Biotechnol. 10, 114–120 (1992).

    Article  CAS  Google Scholar 

  13. Curling, E.M. et al. Recombinant human interferon-γ. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochem. J. 272, 333–337 (1990).

    Article  CAS  Google Scholar 

  14. Gramer, M.J. & Goochee, C.F. Glycosidase activities in Chinese hamster ovary cell lysate and cell culture supernatant. Biotechnol. Prog. 9, 366–373 (1993).

    Article  CAS  Google Scholar 

  15. Paulson, J.C., Weinstein, J. & Schauer, A. Tissue specific expression of sialyltransferases. J. Biol. Chem. 264, 10931–10934 (1989).

    CAS  PubMed  Google Scholar 

  16. Wen, D.X., Svensson, E.C. & Paulson, J.C. Tissue-specific alternative splicing of the βgalactoside α2,6-sialyltransferase gene. J. Biol. Chem. 267, 2512–2518 (1992).

    CAS  PubMed  Google Scholar 

  17. Lee, U.E., Roth, J. & Paulsen, J.C. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of β-galactoside α2,6-sialyltransferase. J. Biol. Chem. 164, 13848–13855 (1989).

    Google Scholar 

  18. Grabenhorst, E., Hoffmann, A., Nimtz, M., Zettmeissl, G. & Conradt H.S. Construction of stable BHK-21 cells co-expressing human secretory glycoproteins and human Gal(β1-4) GlcNAc-r α2,6-sialyltransferase. α2,6-linked NeuAc is preferentially attached to the Gal(β-1-4)GlcNAc(β-1-2)Man(α-1,3)-branch of diantennary oligosaccharides from secreted recombinant βtrace protein. Eur. J. Biochem. 232, 718–725 (1995).

    Article  CAS  Google Scholar 

  19. Minch, S.L., Kallio, P.T. & Bailey, J.E. Tissue plasminogen activator co-expressed in Chinese hamster ovary cells with α-2,6-sialyltransferase contains NeuAc-α(2,6)Gal-β(1,4)GlcNAc linkages. Biotechnol. Prog. 11, 348–351 (1995).

    Article  CAS  Google Scholar 

  20. Monaco, L. et al. Genetic engineering of α2,6 sialyltransferase in recombinant CHO cells and its effect on the sialylation of recombinant interferon-γ. Cytotechnology 22, 197–203 (1996).

    Article  CAS  Google Scholar 

  21. Kitagawa, H. & Paulson, J.C. Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem. Biophys. Res. Commun. 194, 375–382 (1993).

    Article  CAS  Google Scholar 

  22. Masri, K.A., Appert, H.E. & Fukuda, M.N. Identification of the full-length coding sequence for human galactosyltransferase (βN-acetyl-glucosaminide: β-1,4-galactosyltransferase) Biochem. Biophys. Res. Commun. 157, 657–663 (1988).

    Article  CAS  Google Scholar 

  23. Lucas, B.K. et al. High level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Res. 24, 1774–1779 (1996).

    Article  CAS  Google Scholar 

  24. Hilberg, F., Stocking, C., Ostertag, W. & Grez, M. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 84, 5232–5236 (1987).

    Article  CAS  Google Scholar 

  25. Anumula, K.R. Rapid quantitative determination of sialic acids in glycoproteins by high-performance liquid chromatography with a sensitive fluorescence detection. Anal.Biochem. 230, 24–30 (1995).

    Article  CAS  Google Scholar 

  26. Papac, D.I., Briggs, J.B., Chin, E.T. & Jones, A.J.S. A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Glycobiology 8, 445–454 (1998).

    Article  CAS  Google Scholar 

  27. Statistical Consultants PCNONLIN and NONLIN84: Software for the statistical analysis of non-linear models. The Amer. Stat. 40, 52–60 (1986).

Download references

Acknowledgements

The authors would like to acknowledge and thank Mary Sliwkowski, Thomas Warner, and Thomas Ryll of the Analytical Chemistry and Cell Culture & Fermentation Research and Development Departments, Genentech, Inc., for their insightful discussions and helpful comments in the planning of these studies and the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Krummen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weikert, S., Papac, D., Briggs, J. et al. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol 17, 1116–1121 (1999). https://doi.org/10.1038/15104

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/15104

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing